CCL2 and central nervous system cancer: However, as the function of Rab27a in glioma is multifaceted, knocking down Rab27a may have unwarranted downstream effects aside from inhibition of EV release, such as changes in CCL2 expression, and should therefore be used with caution in glioma [97].